Format
Sort by
Items per page

Send to

Choose Destination

Best matches for CANCER LETT[ta]:

The emerging functions and roles of circular RNAs in cancer. Qu S et al. Cancer Lett. (2018)

Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. Banik K et al. Cancer Lett. (2018)

Emerging trends in the immunotherapy of pancreatic cancer. Banerjee K et al. Cancer Lett. (2018)

Search results

Items: 1 to 20 of 13499

1.

Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.

Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C.

Cancer Lett. 2018 Nov 15. pii: S0304-3835(18)30667-0. doi: 10.1016/j.canlet.2018.11.004. [Epub ahead of print]

PMID:
30448543
2.

HHLA2 is a Novel Immune Checkpoint Protein in Pancreatic Ductal Adenocarcinoma and Predicts Post-surgical Survival.

Yan H, Qiu W, Koehne de Gonzalez AK, Wei JS, Tu M, Xi CH, Yang YR, Peng YP, Tsai WY, Remotti HE, Miao Y, Su GH.

Cancer Lett. 2018 Nov 14. pii: S0304-3835(18)30671-2. doi: 10.1016/j.canlet.2018.11.007. [Epub ahead of print]

PMID:
30447255
3.

RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.

Azatyan A, Gallo-Oller G, Diao Y, Selivanova G, Johnsen JI, Zaphiropoulos PG.

Cancer Lett. 2018 Nov 14. pii: S0304-3835(18)30668-2. doi: 10.1016/j.canlet.2018.11.005. [Epub ahead of print]

4.

DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.

Fürst K, Steder M, Logotheti S, Angerilli A, Spitschak A, Marquardt S, Schumacher T, Engelmann D, Herchenröder O, Rupp RAW, Pützer BM.

Cancer Lett. 2018 Nov 13;442:299-309. doi: 10.1016/j.canlet.2018.11.009. [Epub ahead of print]

PMID:
30445206
5.

Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells.

Cetti E, Di Marco T, Mauro G, Mazzoni M, Lecis D, Minna E, Gioiosa L, Brich S, Pagliardini S, Borrello MG, Pruneri G, Anania MC, Greco A.

Cancer Lett. 2018 Nov 13. pii: S0304-3835(18)30674-8. doi: 10.1016/j.canlet.2018.11.010. [Epub ahead of print]

PMID:
30445205
6.

Intratumoral Injection of Gels Containing Losartan Microspheres and (PLG-g-mPEG)-Cisplatin Nanoparticles Improves Drug Penetration, Retention and Anti-tumor Activity.

Yu M, Zhang C, Tang Z, Tang X, Xu H.

Cancer Lett. 2018 Nov 12. pii: S0304-3835(18)30675-X. doi: 10.1016/j.canlet.2018.11.011. [Epub ahead of print]

PMID:
30439541
7.

ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.

Li K, Zhao G, Ao J, Gong D, Zhang J, Chen Y, Li J, Huang L, Xiang R, Hu J, Lin P, Wei Y.

Cancer Lett. 2018 Nov 12;442:271-278. doi: 10.1016/j.canlet.2018.09.033. [Epub ahead of print]

PMID:
30439540
8.

Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.

Huang WT, Chong IW, Chen HL, Li CY, Hsieh CC, Kuo HF, Chang CY, Chen YH, Liu YP, Lu CY, Liu YR, Liu PL.

Cancer Lett. 2018 Nov 12;442:287-298. doi: 10.1016/j.canlet.2018.10.031. [Epub ahead of print]

9.

Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers.

Dai X, Xia H, Zhou S, Tang Q, Bi F.

Cancer Lett. 2018 Oct 26;442:202-212. doi: 10.1016/j.canlet.2018.10.022. [Epub ahead of print]

PMID:
30429107
10.

ADAM28 promotes tumor growth and dissemination of acute myeloid leukemia through IGFBP-3 degradation and IGF-I-induced cell proliferation.

Zhang JM, Wang CC, Zhang GC, Jiang Q, Yang SM, Fu HX, Wang QM, Zhu XL, Zhu HH, Jiang H, Wang Y, Lv M, Lu J, Chen H, Han W, Chang YJ, Kong Y, Xu LP, Liu KY, Huang XJ, Zhang XH.

Cancer Lett. 2018 Oct 26;442:193-201. doi: 10.1016/j.canlet.2018.10.028. [Epub ahead of print]

PMID:
30429106
11.

PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination.

Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, Fujikake K, Yasui H, Yoshikawa N, Suzuki S, Senga T, Shibata K, Kikkawa F.

Cancer Lett. 2018 Oct 26;442:181-192. doi: 10.1016/j.canlet.2018.10.027. [Epub ahead of print]

PMID:
30429105
12.

YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.

Zhong L, Liao D, Zhang M, Zeng C, Li X, Zhang R, Ma H, Kang T.

Cancer Lett. 2018 Nov 10;442:252-261. doi: 10.1016/j.canlet.2018.11.006. [Epub ahead of print]

13.

Targeting AR-Beclin 1 Complex-Modulated Growth Factor Signaling Increases the Antiandrogen-Enzalutamide Sensitivity to Better Suppress the Castration-Resistant Prostate Cancer Growth.

Zhang M, Sun Y, Meng J, Zhang L, Liang C, Chang C.

Cancer Lett. 2018 Nov 10. pii: S0304-3835(18)30672-4. doi: 10.1016/j.canlet.2018.11.008. [Epub ahead of print]

PMID:
30423407
14.

SRC-3 Inhibition Blocks Tumor Growth of Pancreatic Ductal Adenocarcinoma.

Song X, Chen H, Zhang C, Yu Y, Chen Z, Liang H, Van Buren G 2nd, McElhany AL, Fisher WE, Lonard DM, O'Malley BW, Wang J.

Cancer Lett. 2018 Nov 10. pii: S0304-3835(18)30676-1. doi: 10.1016/j.canlet.2018.11.012. [Epub ahead of print]

PMID:
30423406
15.

A20-mediated deubiquitination of ERα in the microenvironment of CD163+ macrophages sensitizes endometrial cancer cells to estrogen.

Lv Q, Xie L, Cheng Y, Shi Y, Shan W, Ning C, Xie B, Yang B, Luo X, He Q, Zhu Q, Zhang Y, Zhang Z, Wang C, Chen X, Xu C.

Cancer Lett. 2018 Oct 27;442:137-147. doi: 10.1016/j.canlet.2018.10.019. [Epub ahead of print]

PMID:
30420335
16.

Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma.

Koemans WJ, Chalabi M, van Sandick JW, van Dieren JM, Kodach LL.

Cancer Lett. 2018 Nov 9;442:279-286. doi: 10.1016/j.canlet.2018.11.001. [Epub ahead of print]

PMID:
30419350
17.

DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC.

Zhang L, Du Y, Xu S, Jiang Y, Yuan C, Zhou L, Ma X, Bai Y, Lu J, Ma J.

Cancer Lett. 2018 Nov 9;442:242-251. doi: 10.1016/j.canlet.2018.11.003. [Epub ahead of print]

PMID:
30419349
18.

Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression.

Ding Y, Cao F, Sun H, Wang Y, Liu S, Wu Y, Cui Q, Mei W, Li F.

Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30660-8. doi: 10.1016/j.canlet.2018.10.039. [Epub ahead of print]

PMID:
30419348
19.

Estrogen-Independent Myc Overexpression Confers Endocrine Therapy Resistance on Breast Cancer Cells Expressing ERαY537S and ERαD538G Mutations.

Yu L, Wang L, Mao C, Duraki D, Kim JE, Huang R, Helferich WG, Nelson ER, Park BH, Shapiro DJ.

Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30662-1. doi: 10.1016/j.canlet.2018.10.041. [Epub ahead of print]

PMID:
30419347
20.

A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus.

Fang J, Hong H, Xue X, Zhu X, Jiang L, Qin M, Liang H, Gao L.

Cancer Lett. 2018 Nov 9;442:222-232. doi: 10.1016/j.canlet.2018.10.040. [Epub ahead of print]

PMID:
30419346

Supplemental Content

Loading ...
Support Center